Cargando…

Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy

Endogenous immune mediated reactions of inflammation and angiogenesis are components of the spinal cord injury in patients with degenerative cervical myelopathy (DCM). The aim of this study was to identify alteration of certain mediators participating in angiogenetic and inflammatory reactions in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Blume, Christian, Geiger, M. F., Müller, M., Clusmann, H., Mainz, V., Kalder, J., Brandenburg, L. O., Mueller, C. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843718/
https://www.ncbi.nlm.nih.gov/pubmed/33510227
http://dx.doi.org/10.1038/s41598-021-81766-8
_version_ 1783644203116396544
author Blume, Christian
Geiger, M. F.
Müller, M.
Clusmann, H.
Mainz, V.
Kalder, J.
Brandenburg, L. O.
Mueller, C. A.
author_facet Blume, Christian
Geiger, M. F.
Müller, M.
Clusmann, H.
Mainz, V.
Kalder, J.
Brandenburg, L. O.
Mueller, C. A.
author_sort Blume, Christian
collection PubMed
description Endogenous immune mediated reactions of inflammation and angiogenesis are components of the spinal cord injury in patients with degenerative cervical myelopathy (DCM). The aim of this study was to identify alteration of certain mediators participating in angiogenetic and inflammatory reactions in patients with DCM. A consecutive series of 42 patients with DCM and indication for surgical decompression were enrolled for the study. 28 DCM patients were included, as CSF samples were taken preoperatively. We enrolled 42 patients requiring surgery for a thoracic abdominal aortic aneurysm (TAAA) as neurologically healthy controls. In 38 TAAA patients, CSF samples were taken prior to surgery and thus included. We evaluated the neurological status of patients and controls prior to surgery including NDI and mJOA. Protein-concentrations of factors with a crucial role in inflammation and angiogenesis were measured in CSF via ELISA testing (pg/ml): Angiopoietin 2, VEGF-A and C, RANTES, IL 1 beta and IL 8. Additionally, evaluated the status of the blood-spinal cord barrier (BSCB) by Reibers´diagnostic in all participants. Groups evidently differed in their neurological status (mJOA: DCM 10.1 ± 3.3, TAAA 17.3 ± 1.2, p < .001; NDI: DCM 47.4 ± 19.7, TAAA 5.3 ± 8.6, p < .001). There were no particular differences in age and gender distribution. However, we detected statistically significant differences in concentrations of mediators between the groups: Angiopoietin 2 (DCM 267.1.4 ± 81.9, TAAA 408.6 ± 177.1, p < .001) and VEGF C (DCM 152.2 ± 96.1, TAAA 222.4 ± 140.3, p = .04). DCM patients presented a mild to moderate BSCB disruption, controls had no signs of impairment. In patients with DCM, we measured decreased concentrations of angiogenic mediators. These results correspond to findings of immune mediated secondary harm in acute spinal cord injury. Reduced angiogenic activity could be a relevant part of the pathogenesis of DCM and secondary harm to the spinal cord.
format Online
Article
Text
id pubmed-7843718
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78437182021-01-29 Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy Blume, Christian Geiger, M. F. Müller, M. Clusmann, H. Mainz, V. Kalder, J. Brandenburg, L. O. Mueller, C. A. Sci Rep Article Endogenous immune mediated reactions of inflammation and angiogenesis are components of the spinal cord injury in patients with degenerative cervical myelopathy (DCM). The aim of this study was to identify alteration of certain mediators participating in angiogenetic and inflammatory reactions in patients with DCM. A consecutive series of 42 patients with DCM and indication for surgical decompression were enrolled for the study. 28 DCM patients were included, as CSF samples were taken preoperatively. We enrolled 42 patients requiring surgery for a thoracic abdominal aortic aneurysm (TAAA) as neurologically healthy controls. In 38 TAAA patients, CSF samples were taken prior to surgery and thus included. We evaluated the neurological status of patients and controls prior to surgery including NDI and mJOA. Protein-concentrations of factors with a crucial role in inflammation and angiogenesis were measured in CSF via ELISA testing (pg/ml): Angiopoietin 2, VEGF-A and C, RANTES, IL 1 beta and IL 8. Additionally, evaluated the status of the blood-spinal cord barrier (BSCB) by Reibers´diagnostic in all participants. Groups evidently differed in their neurological status (mJOA: DCM 10.1 ± 3.3, TAAA 17.3 ± 1.2, p < .001; NDI: DCM 47.4 ± 19.7, TAAA 5.3 ± 8.6, p < .001). There were no particular differences in age and gender distribution. However, we detected statistically significant differences in concentrations of mediators between the groups: Angiopoietin 2 (DCM 267.1.4 ± 81.9, TAAA 408.6 ± 177.1, p < .001) and VEGF C (DCM 152.2 ± 96.1, TAAA 222.4 ± 140.3, p = .04). DCM patients presented a mild to moderate BSCB disruption, controls had no signs of impairment. In patients with DCM, we measured decreased concentrations of angiogenic mediators. These results correspond to findings of immune mediated secondary harm in acute spinal cord injury. Reduced angiogenic activity could be a relevant part of the pathogenesis of DCM and secondary harm to the spinal cord. Nature Publishing Group UK 2021-01-28 /pmc/articles/PMC7843718/ /pubmed/33510227 http://dx.doi.org/10.1038/s41598-021-81766-8 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Blume, Christian
Geiger, M. F.
Müller, M.
Clusmann, H.
Mainz, V.
Kalder, J.
Brandenburg, L. O.
Mueller, C. A.
Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
title Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
title_full Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
title_fullStr Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
title_full_unstemmed Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
title_short Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
title_sort decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843718/
https://www.ncbi.nlm.nih.gov/pubmed/33510227
http://dx.doi.org/10.1038/s41598-021-81766-8
work_keys_str_mv AT blumechristian decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy
AT geigermf decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy
AT mullerm decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy
AT clusmannh decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy
AT mainzv decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy
AT kalderj decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy
AT brandenburglo decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy
AT muellerca decreasedangiogenesisasapossiblepathomechanismincervicaldegenerativemyelopathy